Ultragenyx Pharmaceutical, Inc. (RARE)
16.48
-0.74
(-4.30%)
USD |
NASDAQ |
Nov 20, 16:00
16.48
0.00 (0.00%)
After-Hours: 20:00
Ultragenyx Pharmaceutical Cash and Short Term Investments (Annual) : 693.00M for Dec. 31, 2025
Cash and Short Term Investments (Annual) Chart
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 693.00M |
| December 31, 2024 | 616.83M |
| December 31, 2023 | 579.22M |
| December 31, 2022 | 748.62M |
| December 31, 2021 | 740.20M |
| December 31, 2020 | 1.212B |
| December 31, 2019 | 755.39M |
| December 31, 2018 | 459.98M |
| Date | Value |
|---|---|
| December 31, 2017 | 234.95M |
| December 31, 2016 | 381.56M |
| December 31, 2015 | 437.15M |
| December 31, 2014 | 187.49M |
| December 31, 2013 | 53.38M |
| December 31, 2012 | 86.19M |
| December 31, 2011 | 10.64M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| Ionis Pharmaceuticals, Inc. | 2.677B |
| AbbVie, Inc. | 5.257B |
| Krystal Biotech, Inc. | 827.79M |
| BridgeBio Pharma, Inc. | 588.03M |
| Alnylam Pharmaceuticals, Inc. | 2.908B |